Stimcell Energetics (STME) EBIT Growth (3y) (2019 - 2024)
Stimcell Energetics (STME) EBIT Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 13.22% |
| Feb 29, 2024 | 30.21% |
| Nov 30, 2023 | 38.33% |
| Aug 31, 2023 | 36.00% |
| May 31, 2023 | 35.91% |
| Feb 28, 2023 | 25.33% |
| Nov 30, 2022 | 23.91% |
| Aug 31, 2022 | 15.26% |
| May 31, 2022 | 49.59% |
| Feb 28, 2022 | -38.80% |
| Nov 30, 2021 | -49.86% |
| Aug 31, 2021 | -43.79% |
| May 31, 2020 | 16.83% |
| Feb 29, 2020 | 4.71% |
| Nov 30, 2019 | -7.44% |
| Aug 31, 2019 | 2.50% |
| May 31, 2019 | -56.12% |
| Feb 28, 2019 | 37.19% |